DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair,With death on the horizon, This will not stop me, Gods call only..........
DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 29Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK PHARMA at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contributio

Tuesday, 25 October 2016

Michal Shavit, Scientist at Eloxx Pharmaceutical

Michal Shavit

Michal Shavit

Scientist at Eloxx Pharmaceutical


Image result for Eloxx Pharmaceutical



Eloxx Pharmaceutical
 – Present (2 months)Ness Ziona

Research Scientist

 –  (1 year)Ness Ziona, Israel

Postdoctoral Researcher

Technion - Israel Institute of Technology
 –  (7 months)Haifa

Teaching Assistant

Technion - Israel Institute of Technology
 –  (5 years)Haifa Area, Israel

Research Assistant

Columbia University
 –  (1 year 1 month)


Technion - Israel Institute of Technology

Doctor of Philosophy (PhD), Chemistry

The Hebrew University

Master of Science (MSc), Chmistry

The Hebrew University of Jerusalem

Bachelor’s Degree, Chmistry


Preparation and X-Ray Structures of Ti(IV) Complexes of Bis(carboxylato) Ligands; Formation of Mono-, Di-, Tetra- and Hexanuclear Complexes With or Without OR and μ-O Ligands

Eur. J. Inorg. Chem.
  • --

Synthesis, Characterization, Cytotoxicity, and Hydrolytic Behavior of C2 and C1-Symmetrical Ti(IV) Complexes of Tetradentate Diamine Bis(Phenolato) Ligands: A New Class of Antitumor Agents

Chem. Eur. J
  • --

TiIV Complexes of Branched Diamine Bis(phenolato) Ligands: Hydrolysis and Cytotoxicity

Eur. J. Inorg. Chem.
  • --

Increased Selectivity toward Cytoplasmic versus Mitochondrial Ribosome Confers Improved Efficiency of Synthetic Aminoglycosides in Fixing Damaged Genes: A Strategy for Treatment of Genetic Diseases Caused by Nonsense Mutations

Journal of Medicinal Chemistry

Design of Novel Aminoglycoside Derivatives with Enhanced Suppression of Diseases-Causing Nonsense Mutations

ACS Medicinal Chemistry Letters
February 8, 2016
Image result for Eloxx Pharmaceutical